In contrast, after activation for 12 h, the percentage of granzyme B+ NKG2A− CD8+ T cells from the tumor and normal tissue had a tendency to decrease, but not NKG2A+ CD8+ T cells (Figure 3E). The gene discussed is KLRC1; the disease is neoplasm.